About: LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.35 (-4.01%)
LENZ NASDAQ LENZ Therapeutics Inc
LENZ Therapeutics Inc share price
LENZ price activity
Last Price
$3.350
Change (24hr)
-0.14 USD (4.01%)
Volume
1.45M
Volume (4w avg)
-
Open
$3.38
Day Range
$3.05 - $3.43
Previous Close
$3.49
Last Trade
30 Oct, 3:48 pm GMT+0
Delayed
30 Oct, 3:48 pm GMT+0
LENZ price performance
Delayed
30 Oct, 3:48 pm GMT+0
LENZ Market Signals